2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanenitrile

Catalog No. :
ACEETZ180
CAS No. :
2366279-09-4
Molecular Formula :
C15H20BNO2
Molecular Weight :
257.14

IUPAC Name:2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanenitrile

2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$853.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanenitrile
IUPAC Name2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanenitrile
Molecular FormulaC15H20BNO2
Molecular Weight257.14
SMILESCC(C1=CC=CC(B2OC(C)(C)C(C)(C)O2)=C1)C#N
InChI KeyOOUJEKQQOYAPSM-UHFFFAOYSA-N
SynonymBenzeneacetonitrile, α-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanenitrile
CAS No.2366279-09-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEETZ180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACEETZ180 route product structure diagram
    ACEETZ1802366279-09-4
Inquiry

2. ACEETZ180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  4. Then
  5. ACEETZ180 route product structure diagram
    ACEETZ1802366279-09-4
Inquiry

Comments (0)